Dolby Laboratories (NYSE:DLB) Issues FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 4.300-4.450 for the period, compared to the consensus EPS estimate of 4.110. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q3 2026 guidance to 0.560-0.710 EPS.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Trading Up 1.5%

Shares of NYSE:DLB traded up $0.95 on Thursday, reaching $64.21. 645,872 shares of the company traded hands, compared to its average volume of 720,788. The business’s 50-day simple moving average is $62.58 and its 200 day simple moving average is $64.56. Dolby Laboratories has a 52 week low of $57.62 and a 52 week high of $78.28. The stock has a market capitalization of $6.13 billion, a P/E ratio of 25.89 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.50% and a net margin of 17.97%.The company had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts expect that Dolby Laboratories will post 3.18 EPS for the current fiscal year.

Insider Buying and Selling

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $66.14, for a total value of $198,420.00. Following the completion of the sale, the senior vice president owned 83,218 shares of the company’s stock, valued at approximately $5,504,038.52. The trade was a 3.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Ryan Nicholson sold 2,667 shares of Dolby Laboratories stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $66.38, for a total transaction of $177,035.46. Following the completion of the sale, the chief accounting officer directly owned 36,956 shares of the company’s stock, valued at approximately $2,453,139.28. This trade represents a 6.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 37.93% of the stock is owned by insiders.

Institutional Trading of Dolby Laboratories

Several hedge funds have recently made changes to their positions in DLB. Aquatic Capital Management LLC purchased a new stake in shares of Dolby Laboratories during the 3rd quarter valued at about $56,000. iSAM Funds UK Ltd bought a new position in shares of Dolby Laboratories during the third quarter valued at approximately $68,000. Quarry LP boosted its stake in shares of Dolby Laboratories by 1,486.7% during the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after purchasing an additional 1,115 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Dolby Laboratories during the third quarter valued at approximately $102,000. Finally, US Bancorp DE lifted its position in Dolby Laboratories by 31.3% during the third quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after acquiring an additional 341 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.